Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Kabra Drugs Ltd.
( in Crs.)

ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
      
INCOME     
Revenue From Operations [Net]0.000.000.000.000.02
Total Operating Revenues0.000.000.000.000.02
      
Other Income0.000.010.000.000.00
Total Revenue0.000.010.000.000.02
      
EXPENSES     
Employee Benefit Expenses0.400.230.090.050.00
Depreciation And Amortisation Expenses0.000.000.010.030.03
Other Expenses0.340.110.090.100.05
Total Expenses0.740.340.190.180.08
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-0.74-0.34-0.19-0.18-0.06
      
Profit/Loss Before Tax-0.74-0.34-0.19-0.18-0.06
      
Tax Expenses-Continued Operations     
Profit/Loss After Tax And Before ExtraOrdinary Items-0.74-0.34-0.19-0.18-0.06
      
Profit/Loss From Continuing Operations-0.74-0.34-0.19-0.18-0.06
      
Profit/Loss For The Period-0.74-0.34-0.19-0.18-0.06
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-1.66-0.77-0.42-0.41-0.14
Diluted EPS (Rs.)-1.66-0.77-0.42-0.41-0.14
ParticularsMar 24
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
INCOME 
Revenue From Operations [Net]0.00
Total Operating Revenues0.00
Other Income0.00
Total Revenue0.00
EXPENSES 
Employee Benefit Expenses0.40
Depreciation And Amortisation Expenses0.00
Other Expenses0.34
Total Expenses0.74
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-0.74
Profit/Loss Before Tax-0.74
Tax Expenses-Continued Operations 
Profit/Loss After Tax And Before ExtraOrdinary Items-0.74
Profit/Loss From Continuing Operations-0.74
Profit/Loss For The Period-0.74
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)-1.66
Diluted EPS (Rs.)-1.66